CD8A and COVID-19: Although it has been reported that SARS-CoV-2-specific CD4+ and CD8+ T cells were detected in 100 and 70% of convalescent COVID-19 patients, respectively17, to date, it remains largely unclear how well the SARS-CoV-2 T cell memory is established and how the memory T cells respond upon re-exposure to viral antigens.